Drug Profile


Alternative Names: CG 3703; CNK 602A; NS 3; Remnos

Latest Information Update: 31 May 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Grunenthal
  • Developer Grunenthal; Nippon Shinyaku
  • Class Antidepressants; Antiepileptic drugs; Hormones; Neuroprotectants; Nootropics; Small molecules
  • Mechanism of Action Thyrotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cognition disorders; Epilepsy

Most Recent Events

  • 31 May 2001 Discontinued-II for Cognition disorders in Germany (Unknown route)
  • 31 May 2001 Discontinued-preregistration for Cognition disorders in Japan (Unknown route)
  • 31 May 2001 Discontinued-Unspecified phase in Epilepsy in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top